Kopran Ltd (KOPRAN) Announcements - Latest Exchange Filings with AI Summaries
Latest corporate announcements filed by Kopran Ltd on NSE and BSE, with an AI summary of each filing.
Investor Presentation on Q2 FY 2026-27 Results
Investor Presentation · 03 Nov 2026, 8:39 pm
Kopran Limited Reports Strong Q2 FY26-27 Financial and Operational Performance Kopran Limited delivered robust growth in Q2 FY26-27, with consolidated revenue from operations rising 79.2% YoY to ₹21,126 lakhs. Operating EBITDA surged over sixfold YoY to ₹1,822 lakhs, expanding margins by 609 bps YoY to 8.62%. Net profit reached ₹439 lakhs, rebounding sharply from a net loss of ₹992 lakhs in Q2 FY25-26. For HY'26-27, revenue reached ₹36,526 lakhs with a net profit of ₹1,110 lakhs. API segment revenue totaled ₹12,321 lakhs, led by Carbapenem (₹8,249 lakhs), while formulations contributed ₹8,422 lakhs.
Kopran Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026.
Outcome · 03 Nov 2026, 7:15 pm
Unaudited Results for Q2 FY 2026-27
Outcome · 03 Nov 2026, 7:10 pm
Unaudited results for second quarter ended September 30,2026
Financial Result · 03 Nov 2026, 7:07 pm
Kopran Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Lakh) ■ Revenue: 21,126 (+79.2% YoY | +37.2% QoQ) ■ EBITDA: 1,541 (Loss to Profit YoY | -13.3% QoQ) ■ EBITDA Margin (%): 7.3 (Loss to Profit YoY | -425 bps QoQ) ■ PAT: 439 (Loss to Profit YoY | -34.4% QoQ) ■ EPS (INR): 0.91 (Loss to Profit YoY | -34.5% QoQ)
To consider and approve the financial results for the period ended September 30, 2026
Intimation · 03 Nov 2026, 5:30 am
KOPRAN LIMITED has informed the Exchange about Board Meeting to be held on 03-Nov-2026 to inter-alia consider and approve the Unaudited Financial results of the Company for the Quarterly ended September 2026 .
Intimation · 03 Nov 2026, 5:30 am
Kopran Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/11/2026 ,inter alia, to consider and approve Standalone and Consolidated Unaudited ....
Intimation · 03 Nov 2026, 5:30 am
Kopran Board Meeting Scheduled on 3rd Nov'26 for Q2 Results Kopran Limited has scheduled a Board of Directors meeting on 3rd Nov'26 to consider and approve the unaudited standalone and consolidated financial results for the second quarter ended 30th Sep'26. Additionally, the trading window for dealing in company securities, which has been closed since 1st Oct'26, will reopen 48 hours after the formal declaration of the financial results.
Medicine Authority European Union (EU)- conducted GMP inspection at Company''s Formulation manufacturing facility located at Khopoli is successfully concluded.
Press Release · 22 Oct 2026, 6:31 pm
EU Medicine Authority Concludes GMP Inspection at Kopran's Khopoli Facility The Medicine Authority European Union (EU) concluded its GMP inspection at Kopran Limited’s formulation manufacturing facility in Khopoli, conducted between 18th Sep'26 and 23rd Sep'26. The inspection closed with zero critical observations, zero data integrity issues, one major observation, and certain minor observations. The company is actively preparing its compliance responses and plans to submit them to the EU regulatory authorities within a fortnight.
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Sarvamangal Mercantile Company Ltd
Acquisition/ Disposal of Shares · 01 Oct 2026, 2:16 pm
Sarvamangal Mercantile Acquires 0.35% Additional Stake in Kopran via Open Market Sarvamangal Mercantile Company Ltd., a promoter group entity, acquired 1,70,000 equity shares (0.35% stake) in Kopran Limited through open market purchases on 30th Sep'26. Following this acquisition, Sarvamangal Mercantile's shareholding in Kopran increased from 29,02,951 shares (6.01%) to 30,72,951 shares (6.36% of total voting capital). Kopran Limited's total equity and diluted voting capital remained unchanged at Rs. 48,28,56,050 post-transaction.
Price Movement
Others (Uncategorized) · 22 Sept 2026, 7:47 pm
Kopran Clarifies Significant Share Price Movement as Purely Market Driven Kopran Limited clarified to BSE on 22nd Sep'26 regarding recent significant price movements in its scrip (524280), responding to the exchange's query dated 21st Sep'26. The company confirmed compliance with Regulation 30 of SEBI LODR Regulations, affirming that it has not withheld any undisclosed material information or price-sensitive events that could impact trading behavior. Kopran stated that the increase in its share price is purely market driven.
The Exchange has sought clarification from Kopran Ltd on September 21, 2026 with reference to significant movement in price, in order to ensure that investors have latest relevant information ....
Others (Uncategorized) · 21 Sept 2026, 10:37 pm
Allotment of ESOP Shares
Others (Uncategorized) · 16 Sept 2026, 9:41 pm
Kopran Approves Allotment of 40,500 Equity Shares Under ESOP 2023 Kopran Limited's Corporate Affairs Committee approved the allotment of 40,500 equity shares of face value Rs 10 each on 16th Sep'26 under the Kopran Employee Stock Option Plan 2023. The options were exercised at Rs 179 per share (including a premium of Rs 169 per share). Consequently, the company's paid-up equity share capital increased from 48,285,605 shares (Rs 48.29 cr) to 48,326,105 shares (Rs 48.33 cr). The newly allotted shares rank pari-passu with the existing equity shares.
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for United Shippers Ltd
Acquisition/ Disposal of Shares · 08 Sept 2026, 8:32 pm
United Shippers Sells 2.48% Stake in Kopran via Open Market Promoter group entity United Shippers Limited sold 12,00,000 equity shares, representing a 2.48% stake, in Kopran Limited via an open market transaction on 7th Sep'26. Following the disposal, the entity's shareholding in Kopran decreased from 22,00,000 equity shares (4.56% voting capital) to 10,00,000 equity shares (2.07% voting capital). Kopran's total equity share capital remained unchanged at 4,82,85,605 equity shares post-transaction.
Clarification for Increase in volume across exchanges
Others (Uncategorized) · 01 Sept 2026, 6:12 pm
Kopran Attributes Increased Trading Volume to Market Dynamics On 01 Sep'26, Kopran Limited clarified to the BSE that the significant increase in its trading volume is "purely market driven." The company stated it has made all required disclosures under SEBI Regulations, 2015 and has not withheld any material information or event that would have a bearing on its price or volume. Management confirms there is no undisclosed corporate development causing the stock's increased activity.
The Exchange has sought clarification from Kopran Ltd on September 01, 2026, with reference to Movement in Volume. <BR><BR>The reply is awaited.
Others (Uncategorized) · 01 Sept 2026, 6:02 pm
Proceedings of AGM, Voting results and Scrutinzer report
Annual General Meeting · 18 Aug 2026, 10:22 pm
For Q1 FY 2026-27
Investor Presentation · 07 Aug 2026, 9:27 pm
Kopran Q1 FY27: Revenue Rises 13.9% YoY, Margins Contract Sequentially Kopran reported Q1 FY27 revenue of Rs 15,399 lakh, a 13.9% YoY increase but a 34.2% QoQ decline. EBITDA grew 11.1% YoY to Rs 1,588 lakh, though it fell sharply by 60.9% QoQ. The EBITDA margin contracted to 10.31% from 17.38% in Q4 FY26 and 10.57% in Q1 FY26. Net profit stood at Rs 670 lakh, down 10.1% YoY and 64.5% QoQ. The API and Formulations segments contributed Rs 9,538 lakh and Rs 5,709 lakh to revenues, respectively.
Unaudited Standalone and Consolidated Result for the quarter ended June 30, 2026
Financial Result · 07 Aug 2026, 6:29 pm
Kopran Q1FY27 Results: Consolidated Profit Declines Amidst Sequential Revenue Drop Kopran reported Q1FY27 consolidated net profit of ₹670.09 lakhs, down 10.0% YoY and 64.5% QoQ. Revenue from operations was ₹15,399.43 lakhs, a 13.9% YoY increase but a sharp 34.2% QoQ decline. Consolidated expenses decreased sequentially by 29.5% to ₹14,724.55 lakhs. Standalone results showed a similar trend, with net profit at ₹672.30 lakhs (+91.1% YoY, -64.1% QoQ) on revenue of ₹6,275.79 lakhs (+22.3% YoY, -46.8% QoQ). Consolidated EPS for the quarter stood at ₹1.39.
Unaudited Standalone and Consolidated Result for the Quarter Ended June 30, 2026
Outcome · 07 Aug 2026, 6:18 pm
Kopran Ltd - Financial Result for the Quarter ended 30th Jun'26 (Consolidated, INR Lakhs) ■ Revenue: 15,399 (+13.9% YoY | -34.2% QoQ) ■ EBITDA: 1,778 (+7.6% YoY | -46.0% QoQ) ■ EBITDA Margin (%): 11.5 (-68 bps YoY | -253 bps QoQ) ■ PAT: 670 (-10.0% YoY | -64.5% QoQ) ■ EPS (INR): 1.39 (-9.7% YoY | -64.5% QoQ)
Annual report 2026
Others (Uncategorized) · 25 Jul 2026, 11:48 pm
Kopran Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/08/2026 ,inter alia, to consider and approve Results for the Q1 FY 2026-27
Intimation · 07 Aug 2026, 5:30 am
Kopran Board Meeting on 07 Aug'26 to Approve Q1FY27 Financial Results Kopran has scheduled a Board of Directors meeting for 07 Aug'26 to consider and approve the unaudited standalone and consolidated financial results for the first quarter ending 30 Jun'26. In accordance with regulations, the trading window for dealing in the company's securities, which closed on 01 Jul'26, will reopen 48 hours after the results are declared.
Record Date for Payment of Dividend
Dividend · 17 Jul 2026, 12:32 am
Kopran Announces Record Date for Dividend Payment Kopran Ltd. (BSE: 524280, NSE: KOPRAN) has set Tue, Aug 11, '26 as the record date for its upcoming dividend payment. The dividend payout is subject to shareholder approval at the company's Annual General Meeting (AGM), which is scheduled to be held on Tue, Aug 18, '26. Shareholders on record as of the record date will be eligible to receive the dividend, if declared. The specific dividend amount was not disclosed in the filing.
Appointment of Mr. Vijay L Thange as Chief Technical Officer (CTO) of the Company.
Change in Management · 26 Jun 2026, 10:09 pm
Outcome of NCLT convened meeting for equity shareholders, secured creditor and unsecured creditor held on 03.06.2026
Court Convened Meeting · 05 Jun 2026, 3:48 am
Kopran Shareholders and Creditors Approve Amalgamation Scheme In NCLT-convened meetings on Jun 03, '26, Kopran Limited's proposal for the amalgamation of Kopran Laboratories Limited with itself received overwhelming approval. The resolution was passed by equity shareholders with 99.96% of votes in favour. Separately, the scheme also received unanimous 100% approval from both secured and unsecured creditors in their respective meetings. All resolutions were passed with the requisite majority, clearing a key step for the proposed corporate restructuring.
Investor presentation for 2026.
Investor Presentation · 20 May 2026, 11:14 pm
Kopran Reports Record Q4 FY'26 Revenue and EBITDA Amid Annual Profit Decline Kopran posted its highest-ever quarterly revenue and EBITDA for Q4 FY'26, with revenue from operations at ₹23,402 lakhs, up 36% YoY, and EBITDA at ₹4,057 lakhs, a 190% YoY increase. The EBITDA margin expanded significantly to 17.34% from 8.12% YoY. For the full year FY'26, revenue grew 7.6% YoY to ₹68,142 lakhs. However, annual Net Profit declined by 33% to ₹2,573 lakhs, and full-year EBITDA margin slightly contracted to 11.43%. API and Formulation segments were the key revenue drivers.